Matthew J Betts
Overview
Explore the profile of Matthew J Betts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
2779
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haag L, Lancini E, Yakupov R, Ziegler G, Yi Y, Lusebrink F, et al.
Brain Commun
. 2025 Feb;
7(1):fcaf031.
PMID: 39926613
Neurotransmitter systems of noradrenaline, dopamine, serotonin and acetylcholine are implicated in cognitive functions such as memory, learning and attention and are known to be altered in neurodegenerative diseases like Alzheimer's...
2.
Underwood B, Lourida I, Gong J, Tamburin S, Tang E, Sidhom E, et al.
Alzheimers Dement (N Y)
. 2025 Jan;
11(1):e70037.
PMID: 39839078
Abstract: Recent clinical trials on slowing dementia progression have led to renewed focus on finding safer, more effective treatments. One approach to identify plausible candidates is to assess whether existing...
3.
Ludwig M, Betts M, Hammerer D
Psychophysiology
. 2025 Jan;
62(1):e14753.
PMID: 39815765
The decline in noradrenergic (NE) locus coeruleus (LC) function in aging is thought to be implicated in episodic memory decline. Transcutaneous auricular vagus nerve stimulation (taVNS), which supports LC function,...
4.
Liu K, Betts M, Hammerer D, Duzel E, Mather M, Roiser J, et al.
Brain Commun
. 2025 Jan;
7(1):fcae457.
PMID: 39801712
Hyperphosphorylated tau accumulation is seen in the noradrenergic locus coeruleus from the earliest stages of Alzheimer's disease onwards and has been associated with symptoms of agitation. It is hypothesized that...
5.
Ludwig M, Pereira C, Keute M, Duzel E, Betts M, Hammerer D
Sci Rep
. 2024 Oct;
14(1):24391.
PMID: 39420188
The efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) as a non-invasive method to modulate physiological markers of noradrenergic activity of the Locus Coeruleus (LC), such as pupil dilation, is...
6.
Ludwig M, Pereira C, Keute M, Duzel E, Betts M, Hammerer D
bioRxiv
. 2024 Aug;
PMID: 39131302
The efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) as a non-invasive method to modulate physiological markers of noradrenergic activity of the Locus Coeruleus (LC), such as pupil dilation, is...
7.
Dunnwald M, Krohn F, Sciarra A, Sarkar M, Schneider A, Fliessbach K, et al.
bioRxiv
. 2024 Aug;
PMID: 39091766
Introduction: The Locus Coeruleus (LC) is linked to the development and pathophysiology of neurodegenerative diseases such as Alzheimer's Disease (AD). Magnetic Resonance Imaging based LC features have shown potential to...
8.
Ludwig M, Yi Y, Lusebrink F, Callaghan M, Betts M, Yakupov R, et al.
Commun Biol
. 2024 Jun;
7(1):777.
PMID: 38937535
The locus coeruleus (LC), our main source of norepinephrine (NE) in the brain, declines with age and is a potential epicentre of protein pathologies in neurodegenerative diseases (ND). In vivo...
9.
Hayek D, Ziegler G, Kleineidam L, Brosseron F, Nemali A, Vockert N, et al.
Mol Psychiatry
. 2024 Jan;
29(4):992-1004.
PMID: 38216727
Neuroinflammation is a hallmark of Alzheimer's disease (AD) and both positive and negative associations of individual inflammation-related markers with brain structure and cognitive function have been described. We aimed to...
10.
Chen H, Parent J, Ciampa C, Dahl M, Hammerer D, Maass A, et al.
Front Aging Neurosci
. 2023 Sep;
15:1236335.
PMID: 37744395
Background: The locus coeruleus (LC) produces catecholamines (norepinephrine and dopamine) and is implicated in a broad range of cognitive functions including attention and executive function. Recent advancements in magnetic resonance...